Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.42
$0.0451.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.36% | -70.66% | -93.12% | -160.81% | -162.14% |
| Total Depreciation and Amortization | 32.43% | 91.60% | 125.49% | 160.37% | 170.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.70% | 34.56% | 1.29% | 272.67% | 239.75% |
| Change in Net Operating Assets | 718.03% | 161.39% | 4.58% | 617.35% | 174.06% |
| Cash from Operations | -51.46% | -72.17% | -110.66% | -140.68% | -152.51% |
| Capital Expenditure | 60.69% | 46.27% | 3.19% | -149.79% | -234.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.29% | -41,977.62% | -83,261.36% | -79,919.17% | -60,069.03% |
| Cash from Investing | 107.91% | -3,292.78% | -4,675.94% | -7,414.39% | -9,407.20% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -64.91% | -64.91% | 168,849.37% | 170,846.15% | 127,773.71% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -24.49% | 93.66% | 86.15% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.25% | 89.17% | -550.87% | -- | -- |
| Cash from Financing | -75.50% | -79.08% | 272.17% | 496.17% | 335.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.70% | -184.40% | -80.62% | 214.62% | -57.83% |